Mental Health Clinics in Southaven, MS Accepting Medicare
48 Mental Health Clinics found. Showing 41 - 48
 Healthquest, Pc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6857 Cobblestone Blvd, Southaven, MS 38672 Phone: 901-566-1002 |
Intune Counseling, Llc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 7075 Golden Oaks Loop W Ste 9, Southaven, MS 38671 Phone: 901-361-3470 |
Little And Associates Llc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 8830 Centre St, Suite 5, Southaven, MS 38671 Phone: 662-510-3986 Fax: 662-510-3988 |
Journey To New Beginnings, Pllc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 5627 Getwell Rd, Building B Suite 4, Southaven, MS 38672 Phone: 662-349-2979 Fax: 662-349-2978 |
Integrated Health Counselor - Professional Medicare: Medicare Enrolled Practice Location: 5779 Getwell Rd Bldg D3, Southaven, MS 38672 Phone: 662-510-6507 Fax: 662-510-6508 |
Desoto Family Counseling Center Pllc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 8626 Airways Blvd, Southaven, MS 38671 Phone: 662-772-5937 Fax: 662-772-5940 |
Simple Strokes Behavioral And Mental Health Group Inc Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 83 Airways Pl, Southaven, MS 38671 Phone: 662-349-8787 Fax: 662-349-8757 |
Emotionally Available Counseling Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 8830 Centre St Ste 2, Southaven, MS 38671 Phone: 901-308-7155 Fax: 662-528-4745 |
News Archive
New insight into glutaric acidemia type I
Glutaric acidemia type I (GA-I) is an inherited disorder similar to Huntington disease. Individuals with GA-I are unable to breakdown completely the amino acids lysine and tryptophan and the intermediates of lysine and tryptophan breakdown accumulate in the brain.
Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain
Bioness Inc. today announced the initiation of a study to evaluate the safety and effectiveness of the company's StimRouter Neuromodulation System for those suffering from chronic peripheral nerve pain. This prospective, multi-center, randomized, double-blinded, partial crossover study will enroll 126 patients at up to 10 study sites throughout the United States.
ICF receives IDIQ contract to conduct pilot and evaluation studies, statistical analysis and TTA
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Department of Health and Human Services (HHS), Substance Abuse and Mental Health Services Administration (SAMHSA) to conduct pilot and evaluation studies, statistical analysis, and training and technical assistance (TTA).
Teva asserts infringement of 4 COPAXONE-related patents by Mylan, files complaint in U.S. District Court
Teva Pharmaceutical Industries Ltd. announced today it has filed a complaint in the U.S. District Court for the Southern District of New York against Mylan asserting infringement of four patents related to the characterization of COPAXONE® (glatiramer acetate injection). The latest of these patents expires in February 2020.
› Verified 9 days ago